Skip to main content

452 (Mesalamine Extended-Release 0.375 g)

Pill with imprint 452 is Blue, Capsule-shape and has been identified as Mesalamine Extended-Release 0.375 g. It is supplied by Zydus Pharmaceuticals (USA) Inc.

Mesalamine is used in the treatment of crohn's disease, maintenance; inflammatory bowel disease; ulcerative colitis; ulcerative colitis, maintenance; ulcerative proctitis and belongs to the drug class 5-aminosalicylates. excluding Asacol and Asacol HD: There is no proven risk in humans during pregnancy. Asacol and Asacol HD: Risk cannot be ruled out during pregnancy. Mesalamine 0.375 g is not a controlled substance under the Controlled Substances Act (CSA).

Images for 452

Mesalamine extended-release 0.375 g 452

Mesalamine Extended-Release

0.375 g
Prescription only
Drug Class
Pregnancy Category
B - No proven risk in humans - excluding Asacol and Asacol HD, C - Risk cannot be ruled out - Asacol and Asacol HD
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals (USA) Inc.
Cadila Healthcare Limited
National Drug Code (NDC)
Inactive Ingredients
ethylcellulose (10 mPa.s), hypromellose 2910 (5 mPa.s), methacrylic acid - methyl methacrylate copolymer (1:1), talc, triethyl citrate, FD&C Blue No. 1, gelatin, water, sodium lauryl sulfate, titanium dioxide, ferrosoferric oxide, potassium hydroxide, propylene glycol, shellac, sucrose, corn starch

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "452"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.